Home > Insider Trading > Filing (0001358403-16-000262)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1358403	Bellicum Pharmaceuticals Inc	BLCM	Pharmaceutical Preparations (2834)	201450200

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1627362	M. David Spencer	C/O Bellicum Pharmaceuticals, Inc. 2130 W. Holcombe Blvd., Ste. 800 Houston TX 77030	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2016-09-16	1,700	$20.01	173,382	No	4	S	Direct
Common Stock	Disposition	2016-09-19	700	$20.02	172,682	No	4	S	Direct
Common Stock	Disposition	2016-09-20	100	$20.00	172,582	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 21, 2016 by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.